September 12th 2025
Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.
Optimal approaches to fibroid management
January 1st 2017Fibroids are extremely common in women of reproductive age. One large study reported that 70% of Caucasian and 80% of African-American women had at least one ultrasound- or pathology-confirmed fibroid by the end of their reproductive years. While many of these women experience no negative effects of fibroids on their reproductive function, a significant number are at increased risk of infertility, miscarriage, or poor obstetric outcomes.
Read More
Hysterectomy will ruin my sex life. Orgasm will never be the same!
June 11th 2016How would a male gynecologist begin to know anything about a woman's orgasm? Easy. In my pre-operative counseling for hysterectomy I discuss sexuality, orgasm, and hysterectomy. And I tell my patient that a year later I'm going to ask her about it. But this is not a controlled scientific study, so before telling you what I am hearing, let's look at some real data.
Read More
Are breast density letters too dense?
May 11th 2016A new study looks at whether breast density letters are too difficult for the typical woman to understand. Plus: The FDA issues a warning on fluconazole and miscarriage. Also, do irregular menses provide protection against ovarian cancer or increase risk?
Read More
Does preeclampsia increase risk of infant heart defects?
November 4th 2015A population analysis examines if preeclampsia may serve as a warning sign for heart defects in the neonate. Also, do chlamydia antibodies mean reduced fertility? Plus: Can ovary removal help CVD risk in diabetic women?
Read More
UK approves three-parent fertility treatments and more research
February 11th 2015A form of assisted reproductive technology that could make it possible for women with mutations in mitochondrial DNA to give birth to children free of mitochondrial disease has been approved by UK’s House of Commons. A Food and Drug Administration (FDA) committee is considering granting similar approval for use of the technique-known as oocyte modification or three-parent gene therapy-in the United States.
Read More